MPI Research has appointed Roger N. Hayes, Ph.D., as vice president and general manager of Laboratory Sciences. Dr. Hayes joins the company from Cetero Research, where he served as president of Bioanalytical Operations.

Dr. Hayes has held numerous leadership positions in the global life sciences industry. He spent 10 years at Merck Research Laboratories, where he directed the regulated bioanalysis group in support of preclinical and clinical safety trials and also advanced efficiencies for method development and validation. At Parke-Davis, he managed the instrumentation support department, headed the Bioanalytical Groups for both safety and discovery research, and lead the Drug Metabolism Mass Spectrometry Group. Dr. Hayes also spent several years at Procter and Gamble, where he developed new analytical technology and processes.

According to MPI Research president and chief operating officer, Tim Derrington, “Dr. Hayes is a recognized expert in the field of bioanalytical and analytical testing and we are honored to have him join our leadership team. Under his direction, MPI Research will continue to expand our bioanalytical, immunology, analytical, and biomarker services. Our established scientific team is eager to work with Dr. Hayes as we partner with our pharmaceutical, biotech, chemical, and animal health Sponsors in bringing their products to market.”